Protein microarray analysis of apoptosis-related protein expression following heat shock in human tongue squamous cell carcinomas containing different p53 phenotypes

References

• Wang B. Involvement of p53-dependent apoptosis in radiation teratogenesis and in the radioadaptive response in the late organogenesis of mice. J Radiat Res 2001; 42: 1–10
   PubMedGoogle Scholar
• Friend S. p53: A glimpse at the puppet behind the shadow play. Science 1994; 265: 334–335
   PubMed Web of Science ®Google Scholar
• Hollstein M, Sidransky D, Vogelstein B, Harris CC. p53 mutations in human cancers. Science 1991; 253: 49–53
   PubMed Web of Science ®Google Scholar
• Wang X, Ohnishi T. p53-dependent signal transduction induced by stress. J Radiat Res 1997; 38: 179–194
   PubMed Web of Science ®Google Scholar
• Zhang S, Xu G, Liu C, Xian S, Sun Y, Su X, Cai Y, Li D, Xu B. Clinical study of recombinant adenovirus-p53(Adp53) combined with hyperthermia in advanced cancer. A report of 15 cases. Int J Hyperthermia 2005; 21: 631–636
   PubMed Web of Science ®Google Scholar
• Hurwitz MD, Kaplan ID, Hansen JL, Prokopios-Davos S, Topulos GP, Wishnow K, Manola J, Bornstein BA, Hynynen K. Hyperthermia combined with radiation in treatment of locally advanced prostate cancer is associated with a favorable toxicity profile. Int J Hyperthermia 2005; 21: 649–656
   PubMed Web of Science ®Google Scholar
• Franckena M, Stalpers LJ, Koper PC, Wiggenraad RG, Hoogenraad WJ, van Dijk JD, Wárlám-Rodenhuis CC, Jobsen JJ, van Rhoon GC, van der Zee J. Long-term improvement in treatment outcome after radiotherapy and hyperthermia in locoregionally advanced cervix cancer: An update of the Dutch Deep Hyperthermia. Int J Radiat Oncol Biol Phys 2008; 70: 1176–1182
   PubMed Web of Science ®Google Scholar
• Aktas M, de Jong D, Nuyttens JJ, van der Zee J, Wielheesen DH, Batman E, Burger CW, Ansink AC. Concomitant radiotherapy and hyperthermia for primary carcinoma of the vagina: A cohort study. Eur J Obstet Gynecol Reprod Biol 2007; 133: 100–104
   PubMedGoogle Scholar
• Horsman MR, Overgaard J. Hyperthermia: A potent enhancer of radiotherapy. Clin Oncol 2007; 19: 418–426
   PubMed Web of Science ®Google Scholar
• Westermann AM, Jones EL, Schem BC, van der Steen-Banasik EM, Koper P, Mella O, Uitterhoeve AL, de Wit R, van der Velden J, Burger C, et al. First results of triple-modality treatment combining radiotherapy, chemotherapy, and hyperthermia for the treatment of patients with stage IIB, III, and IVA cervical carcinoma. Cancer 2005; 104: 763–770
   PubMed Web of Science ®Google Scholar
• Kamisawa T, Tu Y, Ishiwata J, Karasawa K, Matsuda T, Sasaki T, Funata N, Tsuruta K, Okamoto A, Takahashi T. Thermo-chemo-radiotherapy for advanced gallbladder carcinoma. Hepatogastroenterol 2005; 52: 1005–1010
   PubMedGoogle Scholar
• Kamisawa T, Tu Y, Egawa N, Karasawa K, Matsuda T, Tsuruta K, Okamoto A. Thermo-chemo-radiotherapy for advanced bile duct carcinoma. World J Gastroenterol 2005; 11: 4206–4209
   PubMedGoogle Scholar
• Xia H, Karesawa K, Hanyu N, Chang TC, Okamoto M, Kiguchi Y, Kawakami M, Itazawa T. Hyperthermia combined with intra-thoracic chemotherapy and radiotherapy for malignant pleural mesothelioma. Int J Hyperthermia 2006; 22: 613–621
   PubMed Web of Science ®Google Scholar
• Milani V, Pazos M, Issels RD, Buecklein V, Rahman S, Tschoep K, Schaffer P, Wilkowski R, Duehmke E, Schaffer M. Radiochemotherapy in combination with regional hyperthermia in preirradiated patients with recurrent rectal cancer. Strhlenther Onkol 2008; 184: 163–168
   PubMed Web of Science ®Google Scholar
• Yasumoto J, Kirita T, Takahashi A, Ohnishi K, Imai Y, Yuki K, Ohnishi T. Apoptosis-related gene expression after hyperthermia in human tongue squamous cell carcinoma cells harboring wild-type or mutated-type p53. Cancer Lett 2004; 204: 41–51
   PubMedGoogle Scholar
• Yasumoto J, Imai Y, Takahashi A, Ohnishi K, Yuki K, Kirita T, Ohnishi T. Analysis of apoptosis-related gene expression after X-ray irradiation in human tongue squamous cell carcinoma cells harboring wild-type or mutated p53 gene. J Radiat Res 2003; 44: 41–45
   PubMedGoogle Scholar
• Ota I, Ohnishi K, Takahashi A, Yane K, Kanata H, Miyahara H, Ohnishi T, Hosoi H. Transfection with mutant p53 gene inhibits heat-induced apoptosis in a head and neck cell line of human squamous cell carcinoma. Int J Radiat Oncol Biol Phys 2000; 47: 495–501
   PubMed Web of Science ®Google Scholar
• Jia LQ, Osada M, Ishioka C, Gamo M, Ikawa S, Suzuki T, Shimodaira H, Niitani T, Kudo T, Akiyama M, et al. Screening the p53 status of human cell lines using a yeast functional assay. Mol Carcinog 1997; 19: 243–253
   PubMed Web of Science ®Google Scholar
• Kern SE, Pietenpol JA, Thiagalingam S, Seymour A, Kinzler KW, Vogelstein B. Oncogenic forms of p53 inhibit p53-regulated gene expression. Science 1992; 256: 827–830
   PubMed Web of Science ®Google Scholar
• Kim PK, Wang Y, Gambotto A, Kim TM, Weller R, Zuckerbraun BS, Hua Y, Watkins SC, Billiar TR. Hepatocyte Fas-associating death domain protein/mediator of receptor-induced toxicity (FADD/MORT1) levels increase in response to pro-apoptosis stimuli. J Biol Chem 2002; 277: 38855–38862
   PubMedGoogle Scholar
• Sawada M, Sun W, Hayes P, Leskov K, Boothman DA, Matsuyama S. Ku70 suppresses the apoptotic translocation of Bax to mitochondria. Nat Cell Biol 2003; 5: 320–329
   PubMed Web of Science ®Google Scholar
• Bharti A, Kraeft SK, Gounder M, Pandey P, Jin S, Yuan ZM, Lees-Miller SP, Weichselbaum R, Weaver D, Chen LB, et al. Inactivation of DNA-dependent protein kinase by protein kinase Cδ: Implications for apoptosis. Mol Cell Biol 1998; 18: 6719–6728
   PubMed Web of Science ®Google Scholar
• Chen N, Ma W, Huang C, Dong Z. Translocation of protein kinase Cipsilon and protein kinase Cδ to membrane is required for ultraviolet B-induced activation of mitogen-activated protein kinases and apoptosis. J Biol Chem 1999; 274: 15389–15394
   PubMedGoogle Scholar
• DeGregori J, Leone G, Miron A, Jakoi L, Nevins JR. Distinct roles for E2F proteins in cell growth control and apoptosis. Proc Natl Acad Sci USA 1997; 94: 7245–7250
   PubMed Web of Science ®Google Scholar
• van Malle W, Wielodkx B, Mahieu T, Takada M, Taniguchi T, Sekikawa K, Libert C. HSP70 protects against TNF-induced lethal inflammatory shock. Immunity 2002; 16: 685–695
   PubMedGoogle Scholar
• Margulies L, Sehgal PB. Modulation of the human interleukin-6 promoter (IL-6) and transcription factor C/EBP beta (NF-IL6) activity by p53 species. J Biol Chem 1993; 268: 15096–15100
   PubMed Web of Science ®Google Scholar
• Budhram-Mahadeo V, Morris PJ, Smith MD, Midgley CA, Boxer LM, Latchman DS. p53 suppresses the activation of the Bcl-2 promoter by the Brm-3a POU family transcription factor. J Biol Chem 1999; 274: 15237–15244
   PubMed Web of Science ®Google Scholar
• Sugars KL, Budhram-Mahadeo V, Packham G, Latchman DS. A minimal Bcl-x promoter is activated by Brn-3a and repressed by p53. Nucleic Acid Res 2001; 29: 4530–4540
   PubMed Web of Science ®Google Scholar
• Gu L, Zhu N, Findley HW, Woods WG, Zhou M. Identification and characterization of the IKKα promoter: Positive and negative regulator by ETS-1 and p53, respectively. J Biol Chem 2004; 279: 52141–52149
   PubMed Web of Science ®Google Scholar
• Ohnishi K, Yuki K, Ohnishi T. Hyperthermic cancer therapy combined with inhibitors targeted against heat-induced signaling factors. Jpn J Hyperthermic Oncol 2004; 20: 143–159
   Google Scholar
• Anderson L, Seilhamer J. A comparison of selected mRNA and protein abundances in human liver. Electrophoresis 1997; 18: 533–537
   PubMed Web of Science ®Google Scholar